Some users of GLP-1 weight-loss drugs have been reporting strange changes in food preferences, such as a new dislike for ...

also known as the type 2 diabetes treatment Ozempic, and tirzepatide, which is used to treat type 2 diabetes and obesity, and the mechanism behind this. A former food reporter, Alyssa Fraser ...

But while the drug is known for its powerful appetite-suppressing effects, some users are reporting dramatic shifts in how food tastes. These Ozempic-driven taste changes can include strong ...

New research finds that Ozempic can have a big impact on the food choices people make. People on the medication take in significantly fewer calories than others. They also make very distinct food ...

Fraser, a former food reporter from Minnesota ... there needs to be more research on that." —$3 million Breakthrough Prize awarded to developers of Ozempic-style drugs —Ozempic-style drugs ...

Some research backs up these personal accounts, including a study published in Food Quality and Preference. It found that people on GLP-1 drugs like Wegovy and Ozempic reported eating fewer processed ...

New research finds that Ozempic can have a big impact on the food choices people make. People on the medication take in significantly fewer calories than others. They also make very distinct food ...

The announcement follows new research that suggested drugs like Wegovy, Mounjaro and Ozempic slashed the risk of contracting the disease. Scientists from Israel said the drugs, also known as GLP ...

How much of these do you need to eat daily though to have the same impact as Ozempic?' one commenter asked. Another explained that these foods don't 'eliminate the food noise that goes away on a ...

Ozempic (semaglutide) is a medication approved by the Food and Drug Administration (FDA ... both effective for blood sugar management, some research shows that Mounjaro might be more effective ...

The research team plans to monitor 1,200 patients over five years to assess long-term benefits and safety of Ozempic in liver disease treatment.

Ozempic, a diabetes drug, shows promise for liver disease. Research indicates it can reverse non-alcoholic steatohepatitis. A study reveals significant liver health improvements in patients.